Akums Drugs & Pharmaceuticals Limited made an impressive debut on the stock exchanges, listing on August 6, 2024, at a price of ₹725, which is a 6.77% premium over its IPO issue price of ₹679. The Akums Drugs share price has seen steady interest from investors, currently trading around ₹725 on both the NSE and BSE. The IPO was a massive success, being oversubscribed by 63.56 times, with a significant push from qualified institutional buyers (90.09 times) and retail investors (21.3 times). If you’re interested in analyzing stocks like this, consider learning from GRM IIT—check out our YouTube channel for free tutorials or visit our website for comprehensive courses.
Akums Drugs Share Price Overview
- Current NSE Price: ₹725
- Current BSE Price: ₹725
The Akums Drugs share price NSE and Akums Drugs share price BSE have been stable since their market debut, making it a stock worth monitoring closely, especially amid current market volatility.
Akums Drugs & Pharmaceuticals Ltd IPO Highlights
- IPO Price Range: ₹646 – ₹679
- Listing Date: August 6, 2024
- Lot Size: 22 shares per lot
- Total Issue Size: ₹1,856.74 crore
The Akums Drugs & Pharmaceuticals Ltd IPO garnered massive investor interest, especially among institutional buyers, leading to its impressive oversubscription. The stable Akums Drugs share price post-listing reflects investor confidence in the company’s long-term growth prospects.
Akums Drugs Share Price Target Analysis
Short-Term Target for 2024
Analysts suggest a short-term target for the Akums Drugs share price to be around ₹800 to ₹850 by the end of 2024, based on market trends and the company’s growth trajectory.
- Akums Drugs share price target 2024: ₹800 – ₹850
Long-Term Share Price Targets
- Akums Drugs share price target 2025: ₹950
- Akums Drugs share price target 2026: ₹1,100
- Akums Drugs share price target 2027: ₹1,250
- Akums Drugs share price target 2028: ₹1,400
- Akums Drugs share price target 2029: ₹1,600
- Akums Drugs share price target 2030: ₹1,800
The projected Akums Drugs share price targets indicate strong long-term growth potential, making it an attractive option for investors looking to add a solid pharmaceutical stock to their portfolio.
Analyzing Akums Drugs Share Price Chart
Investors can keep track of the Akums Drugs share price chart on financial platforms like Screener, NSE, and BSE. These platforms provide real-time data, helping you analyze historical performance and trends in the Akums Drugs share price.
Key Investment Insights for Akums Drugs
- Market Volatility: The Akums Drugs share price NSE and Akums Drugs share price BSE may fluctuate due to broader market conditions and sector-specific factors, especially in the pharmaceutical industry.
- Strong Fundamentals: Akums has a diversified product portfolio and robust demand in both domestic and international markets, making it well-positioned for future growth.
- Long-Term Growth Potential: The company’s strategic positioning in the pharma sector aligns with the increasing demand for healthcare products, driving optimistic Akums Drugs share price targets for the coming years.
Conclusion: Is Akums Drugs a Good Investment?
Given its strong fundamentals and optimistic Akums Drugs share price targets, Akums Drugs & Pharmaceuticals Ltd could be a solid investment for those looking for exposure to the pharmaceutical sector. However, short-term investors should exercise caution due to potential market volatility.
If you want to learn how to analyze stocks like Akums Drugs share price or even better, consider exploring educational resources from GRM IIT. Our YouTube channel offers free tutorials, and our website provides in-depth paid courses to elevate your trading and investment skills.
📈 Ready to Start Your Investment Journey? Open Your Demat Account Now!
Looking to invest in stocks like Akums Drugs share price? Open your Demat account with GRM Bulls for comprehensive financial services and support.
Partner with GRM Bulls for expert financial assistance and seamless trading experiences. Don’t miss out on the opportunity to grow your wealth with the best in the industry!
